Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

SoCCC Pre-Rounds: Bite-Sized Critical Care Cardiology Topics Delivered By Experts

Claim This Podcast

by Dr. Balim Senman, Dr. Elliott Miller, Dr. Simon Parlow, Dr. Anthony Carnicelli

4.0(5 reviews)

13 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Authority

Beta

PoorBased on show quality, social media presence, reviews, charts, and more

Quality18

Social0

YouTube0

Engagement31

Learn more

Podcast Overview

SoCCC Pre-Rounds is your go-to for quick, high-yield insights in critical care cardiology, hosted by members of the Society of Critical Care Cardiology (SoCCC). With only 160 specialists in the U.S., mentorship is rare. This podcast bridges the gap with bite-sized episodes featuring clinical pearls, expert tips, and real-world answers on topics like cardiogenic shock, ECMO, and resuscitation. Perfect for pre-rounds, night shifts, or leveling up anytime. Listen in. Level up. Join the SoCCC community.

Language

🇺🇲

Publishing Since

6/23/2025

Visit Website View on Apple Podcasts RSS Feed

🇺🇸 Charts #3

Outreach generated

Apple 142

Spotify 827

Instant mention tracking

Perfect fit!

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

Podcast Authority

Beta

PoorBased on show quality, social media presence, reviews, charts, and more

Quality18

Social0

YouTube0

Engagement31

Learn more

Excellent Areas

Good Performance

Growth Opportunities

excellent

Episode Length

14 minutes

Performing excellently!

good

Show Notes Quality

3.0/5

Recommendations available

Unlock the full report to see detailed tips

needs improvement

Publishing Consistency

Every 25 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

• YouTube presence analysis
• Social media reach metrics
• RSS compliance scoring
• Podcast 2.0 features
• Technical standards

What's Included in Your Full Report

Detailed Analytics

Complete breakdown of all 19 authority metrics
Personalized recommendations for each metric
Industry benchmarks and comparisons
Technical RSS feed analysis and compliance scoring

Growth Strategies

Step-by-step action plans for improvement
Quick wins to boost your score immediately
Pro tips from successful podcasters

Get your free podcast insights report

See how your show performs across every key metric

Instant delivery

No spam

Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for SoCCC Pre-Rounds: Bite-Sized Critical Care Cardiology Topics Delivered By Experts

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

July 3, 2026

Vasoactive Medications in the CICU with Dr. Elliott Miller and Dr. Anthony Carnicelli

How do you choose the right vasoactive medication for a patient in cardiogenic shock? In this episode of SoCCC Pre-Rounds, hosts Dr. Anthony Carnicelli and Dr. Elliott Miller sit down for a practical, high-yield discussion on vasopressors, inotropes, and the real-world decision-making behind vasoactive medication management in the CICU.Designed for residents, fellows, and ICU teams, this episode breaks down the pharmacology, clinical evidence, and bedside application of commonly used vasoactive agents including norepinephrine, dopamine, epinephrine, vasopressin, phenylephrine, dobutamine, and milrinone.Dr. Carnicelli emphasizes a stepwise approach to vasoactive medication management: first understanding the pharmacology and intended physiologic effects, then learning how to apply those principles clinically in complex shock states. The conversation explores the limitations of existing cardiogenic shock data, including the aging SOAP II trial and the landmark DOREMI trial comparing milrinone and dobutamine.The discussion also dives into nuanced scenarios such as LVOT obstruction, severe aortic stenosis, pulmonary hypertension, arrhythmogenic shock, and escalating vasopressor requirements that may signal the need for mechanical circulatory support.Packed with practical teaching pearls and candid reflections from the CICU, this episode offers a thoughtful framework for approaching vasoactive medications beyond algorithms and dogma. Whether you are pre-rounding before sunrise or managing a crashing patient overnight, this episode delivers actionable insights you can apply immediately at the bedside. <ul><li>Norepinephrine remains the preferred first-line vasopressor in most cardiogenic shock patients.</li><li>Vasopressin is generally avoided in low-output cardiogenic shock due to pure vasoconstrictive effects.</li><li>Pulmonary hypertension and arrhythmogenic shock may be scenarios where vasopressin is helpful.</li></ul><ul><li>DOREMI demonstrated no major efficacy or safety differences between milrinone and dobutamine.</li><li>Vasoactive medication management is often more art than science.</li></ul> <ul><li>[00:00] Introduction </li><li>[01:51] A two-step approach to teaching vasoactive meds</li><li>[03:30] The SOAP II trial: Norepinephrine vs. dopamine</li><li>[06:41] Epinephrine as a first-line agent</li><li>[08:19] When to avoid norepinephrine</li><li>[09:57] Using vasopressin in cardiogenic shock</li><li>[12:32] Phenylephrine in right heart failure</li><li>[13:48] The DOREMI trial: Milrinone vs. dobutamine</li><li>[17:32] Final thoughts and interdisciplinary approaches</li></ul> <ul><li>[07:37] " Even if you're defending the MAP with epinephrine, you'll get this characteristic rise in lactate, which is concerning, to say the least." — Dr. Elliott Miller</li></ul><ul><li>[15:36] "The fact that in a randomized trial there was no evidence of efficacy difference, no difference in survival, but also no difference in safety profile…that speaks volumes." — Dr. Anthony Carnicelli on the DOREMI trial</li></ul><ul><li>[17:07] "If you choose milrinone and you've made a mistake, you're going to have to live with that mistake for a lot longer than dobutamine." — Dr. Elliott Miller</li></ul><ul><li>[18:51] "Vasoactive medication management is a bit more of an art than it is a science. So experience goes a long way." — Dr. Anthony Carnicelli</li></ul>Resources and Links<ul><li>Become a member of the Community: <a href="https://www.soccc.org/subscribe">https://www.soccc.org/subscribe</a></li></ul>Dr. Anthony Carnicelli<ul><li><a href="https://www.getcare.muschealth.org/providers/anthony-carnicelli-1376956714">https://www.getcare.muschealth.org/providers/anthony-carnicelli-1376956714</a></li><li><a href="https://www.linkedin.com/in/anthony-carnicelli-926a0b88">https://www.linkedin.com/in/anthony-carnicelli-926a0b88</a></li></ul>Dr. Elliott Miller<ul><li><a href="https://x.com/ElliottMillerMD">https://x.com/ElliottMillerMD</a></li><li><a href="https://www.soccc.org/">https://www.soccc.org/</a></li></ul>Supported By:This episode is made possible by unrestricted support from <a href="https://cardiac.zoll.com/patients/lifevest?utm_term=life%20vest%20cardiac&utm_campaign=Cardiac+-+LifeVest+Patients&utm_source=adwords&utm_medium=ppc&hsa_acc=3725084088&hsa_cam=22620204946&hsa_grp=184004443847&hsa_ad=755140542390&hsa_src=g&hsa_tgt=kwd-2422787973254&hsa_kw=life%20vest%20cardiac&hsa_mt=b&hsa_net=adwords&hsa_ver=3&gad_source=1&gad_campaignid=22620204946&gbraid=0AAAAADqfl7Q-s3_-V8Hkd__LS91jIXf69&gclid=CjwKCAjwsZPDBhBWEiwADuO6y4FsrFZuMqyJYSsOtaDxoS4MidynidBRdOuw34-wjC3TvENsvThC4xoC188QAvD_BwE">Zoll LifeVest </a>— thanks for keeping high-impact education free for our community.DisclaimerThis podcast is not medical advice, just candid, practical discussions about what your hosts do every day in the CICU. Always consult your supervising team and current guidelines before applying any interventions.

June 5, 2026

The Story of DanGer Shock and the Future of the Microaxial Flow Pump with Dr. Jacob Møller

After more than two decades without a major positive randomized trial in cardiogenic shock, is the evidence finally catching up to the technology? In this episode of SoCCC Pre-Rounds, Dr. Simon Parlow sits down with Dr. Jacob Møller, critical care cardiologist and professor at the University Hospital Copenhagen, to unpack microaxial flow pumps and the landmark DanGer Shock trial. Dr. Møller shares how persistence, collaboration, and a bit of luck helped drive a breakthrough in a field that has long needed one.They explore how these devices work at the bedside, from unloading the left ventricle to reducing myocardial oxygen demand, and what that means in real-world care. The conversation also dives into the challenges of running a high-stakes trial in critically ill patients, along with practical insights on patient selection, complications, lactate trends, and weaning strategies. It’s a sharp look at one of the most important recent advances in cardiogenic shock and where clinicians are still forced to operate without clear evidence. <ul><li>Microaxial flow pumps unload the left ventricle: By reducing preload and stroke work, they may lower myocardial oxygen demand and support recovery in shock states.</li><li>The DanGer Shock trial changes the landscape: It’s the first major positive randomized trial in cardiogenic shock in over 20 years, targeting a highly selected STEMI population.</li><li>Patient selection is everything: Only a small fraction of shock patients were eligible, highlighting how precise clinicians must be when applying this therapy.</li><li>Weaning starts earlier than we thought: The most critical window may be the first 12–24 hours, with earlier reassessment for device removal.</li><li>Evidence is still evolving: Outside of trial populations, clinicians must rely on judgment when considering use in non-STEMI or non-ischemic shock.</li></ul> <ul><li>[00:00] Introduction to SoCCC Pre-Rounds</li><li>[00:57] Live from ACVC 2026: introducing Dr. Jacob Møller</li><li>[01:15] What are micro axial flow pumps and how do they work?</li><li>[03:52] The origin and evolution of the DanGer Shock trial</li><li>[06:39] Trial results and why they were unexpected</li><li>[07:48] Expanding beyond STEMI: real-world patient selection</li><li>[09:44] Monitoring patients: lactate and hemodynamic trends</li><li>[10:20] Early management challenges and complications</li><li>[11:36] Rethinking weaning strategies</li><li>[12:05] Role of guideline-directed therapy during support</li><li>[12:57] Lessons from running a major clinical trial</li><li>[14:03] Building a research culture in critical care</li></ul> <ul><li>[07:51] "After seeing the results of DanGer, we have probably become a little bit more liberal in using the device in other forms of ischemic, like non-STEMI shock." — Dr. Jacob Møller</li></ul><ul><li>[09:46] "We look at trajectories, and we look a lot at lactate. Lactate has to go down in these patients; otherwise, something is wrong." — Dr. Jacob Møller</li></ul><ul><li>[10:33] "You look at the trajectory, so if it goes from 1.5 and starts going down, then you know there's something wrong." — Dr. Jacob Møller</li></ul><ul><li>[13:57] "I'm working in a very small cardiac ICU; we only have seven beds, but we randomized more than 100 patients with out-of-hospital cardiac arrest every year." — Dr. Jacob Møller</li></ul> <ul><li>Become a member of the Community: <a href="https://www.soccc.org/subscribe">https://www.soccc.org/subscribe</a></li></ul>Dr. Jacob Møller<ul><li><a href="https://www.linkedin.com/in/jacob-eifer-m%C3%B8ller-1b2398300/?locale=en">https://www.linkedin.com/in/jacob-eifer-m%C3%B8ller-1b2398300/?locale=en</a></li><li><a href="https://www.rigshospitalet.dk/">https://www.rigshospitalet.dk/</a></li></ul>Dr. Simon Parlow<ul><li><a href="https://www.ottawaheart.ca/profile/parlow-simon">https://www.ottawaheart.ca/profile/parlow-simon</a></li></ul>Supported By:This episode is made possible by unrestricted support from <a href="https://cardiac.zoll.com/patients/lifevest?utm_term=life%20vest%20cardiac&utm_campaign=Cardiac+-+LifeVest+Patients&utm_source=adwords&utm_medium=ppc&hsa_acc=3725084088&hsa_cam=22620204946&hsa_grp=184004443847&hsa_ad=755140542390&hsa_src=g&hsa_tgt=kwd-2422787973254&hsa_kw=life%20vest%20cardiac&hsa_mt=b&hsa_net=adwords&hsa_ver=3&gad_source=1&gad_campaignid=22620204946&gbraid=0AAAAADqfl7Q-s3_-V8Hkd__LS91jIXf69&gclid=CjwKCAjwsZPDBhBWEiwADuO6y4FsrFZuMqyJYSsOtaDxoS4MidynidBRdOuw34-wjC3TvENsvThC4xoC188QAvD_BwE">Zoll LifeVest </a>— thanks for keeping high-impact education free for our community.DisclaimerThis podcast is not medical advice, just candid, practical discussions about what your hosts do every day in the CICU. Always consult your supervising team and current guidelines before applying any interventions.

May 1, 2026

Keeping It Cool: The Evidence, the Controversy, the Future of TTM with Dr. Andrea Elliott

In this episode of SoCCC Pre-Rounds, Dr. Balim Senman and Dr. Andrea Elliott, a cardiologist and critical care physician at the University of Minnesota, dive into the evolving landscape of targeted temperature management (TTM) after cardiac arrest. They explore how temperature control strategies have shifted from early hypothermia trials to modern fever-avoidance methods, with ongoing debates around TTM in critical care. Dr. Elliott discusses landmark studies like Bernard, HACA, TTM, Hyperion, and TTM2, highlighting their impact and limitations.The conversation delves into the real-world application of temperature targets, considering patient severity, neurologic injury, and the unique challenges posed by ECPR patients. Dr. Elliott also covers the physiological costs of hypothermia, common complications, and practical aspects of managing shivering, devices, and protocols. Whether you're a trainee or an experienced clinician, this episode offers evidence-based insights and practical guidance for optimizing post-arrest care. <ul><li>TTM is for comatose survivors: Only patients who remain unresponsive after ROSC benefit; awake patients do not.</li><li>Fever prevention matters most: Trial data on hypothermia vs normothermia are mixed, but fever (>37.7°C) is consistently harmful and must be aggressively avoided.</li><li>One size does not fit all: Patients with longer downtimes or more severe neurologic injury may benefit more from active cooling. Allowing spontaneous hypothermia is reasonable.</li><li>ECPR patients are different: Prolonged CPR and ECMO-based temperature control make them physiologically distinct from patients in major TTM trials.</li></ul> <ul><li>[00:00] Introduction</li><li>[02:16] Historical background of TTM</li><li>[03:13] Early human studies and mechanisms</li><li>[04:17] Landmark trials Bernard and HACA</li><li>[06:06] TM1 Hyperion and TM2 trials</li><li>[10:25] Patient selection for TTM</li><li>[11:39] Personalized temperature targeting</li><li>[13:21] Management of hypothermic and normothermic patients</li><li>[15:47] TTM in ECPR and ECMO patients</li><li>[18:09] Drawbacks and risks of hypothermia</li><li>[19:19] Protocols and cooling devices</li><li>[21:59] ECPR-specific cooling techniques</li></ul> <ul><li>[16:04] "ECPR patients by definition have had refractory arrest, not attaining ROSC. So that 20- 25 minute time is blown out of the water. Our ECPR population has an average of 60 minutes of CPR time, so more than double. So the time for that neurologic injury is extensive." — Dr. Andrea Elliott</li></ul><ul><li>[18:43] "You can actually get into trouble if with some under-resuscitation and some patients, if you get them too cold too quickly, and so you'll have to give extra volume back."— Dr. Andrea Elliott</li></ul><ul><li>[22:37] "The most important thing is to make sure that you avoid fevers in our ECPR patients. We also use cooling towers, so we basically cool the fluid or the blood that is in the tubing outside of the patient so that it goes through a cooling bath."— Dr. Andrea Elliott</li></ul> <ul><li>Become a member of the Community: <a href="https://www.soccc.org/subscribe">https://www.soccc.org/subscribe</a></li></ul>Dr. Andrea Elliott<ul><li><a href="https://med.umn.edu/bio/andrea-elliott">https://med.umn.edu/bio/andrea-elliott</a></li><li><a href="https://www.linkedin.com/in/andrea-elliott-5575b4267/">https://www.linkedin.com/in/andrea-elliott-5575b4267/</a></li></ul>Dr. Balim Senman<ul><li><a href="https://www.linkedin.com/in/balim-senman-7561436b/">https://www.linkedin.com/in/balim-senman-7561436b/</a></li><li><a href="https://x.com/BalimSenmanMD">https://x.com/BalimSenmanMD</a></li><li><a href="https://www.soccc.org/">https://www.soccc.org/</a></li></ul>Supported By:This episode is made possible by unrestricted support from <a href="https://cardiac.zoll.com/patients/lifevest?utm_term=life%20vest%20cardiac&utm_campaign=Cardiac+-+LifeVest+Patients&utm_source=adwords&utm_medium=ppc&hsa_acc=3725084088&hsa_cam=22620204946&hsa_grp=184004443847&hsa_ad=755140542390&hsa_src=g&hsa_tgt=kwd-2422787973254&hsa_kw=life%20vest%20cardiac&hsa_mt=b&hsa_net=adwords&hsa_ver=3&gad_source=1&gad_campaignid=22620204946&gbraid=0AAAAADqfl7Q-s3_-V8Hkd__LS91jIXf69&gclid=CjwKCAjwsZPDBhBWEiwADuO6y4FsrFZuMqyJYSsOtaDxoS4MidynidBRdOuw34-wjC3TvENsvThC4xoC188QAvD_BwE">Zoll LifeVest </a>— thanks for keeping high-impact education free for our community.DisclaimerThis podcast is not medical advice, just candid, practical discussions about what your hosts do every day in the CICU. Always consult your supervising team and current guidelines before applying any interventions.

13 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Cardionerds: A Cardiology Podcast

CardioNerds

Critical Care Time

Critical Care Time Podcast

EMCrit FOAM Feed

Scott D. Weingart, MD FCCM

This Week in Cardiology

Medscape

The Daily

The New York Times

The Ezra Klein Show

New York Times Opinion

Matter of Opinion

New York Times Opinion

PulmPEEPs

Mayo Clinic Cardiovascular CME

Mayo Clinic

ICUedu

Sara Crager

Sensible Medicine

Sensible Medicine Authors and Editors

Deep-dive analytics for SoCCC Pre-Rounds: Bite-Sized Critical Care Cardiology Topics Delivered By Experts

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is SoCCC Pre-Rounds: Bite-Sized Critical Care Cardiology Topics Delivered By Experts?: SoCCC Pre-Rounds is your go-to for quick, high-yield insights in critical care cardiology, hosted by members of the Society of Critical Care Cardiology (SoCCC). With only 160 specialists in the U.S., mentorship is rare. This podcast bridges the gap with bite-sized episodes featuring clinical pearls, expert tips, and real-world answers on topics like cardiogenic shock, ECMO, and resuscitation. Perfect for pre-rounds, night shifts, or leveling up anytime. Listen in. Level up. Join the SoCCC community.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Information about guest appearances is not available.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.